Hacker News Reader

Yes, something is definitely missing from this story!

I thought on first skim perhaps they were leaving out the difficulty of manufacturing mRNA vaccines in volume (there's a classic popular trope, especially with respect to medicine for some reason, of invention being 99% of getting something to market.

However from what limited info is in the article it appears to be something quite easy to manufacture on existing infrastructure.

View on HN

> they were leaving out the difficulty of manufacturing mRNA vaccines in volume

Article is about adenovirus vaccine, not mRNA vaccine.

Yes that’s what I meant: it isn’t mRNA (my reflexive presumption for something quick these days) and, as a nasal spray, is presumably something conventional, quick amd stable. Seems crazy to have ignored it, based only on what I see in this article.

Reply on news.ycombinator.com